Kuala Lumpur (ANTARA News/Bernama) - Cellsafe International Group, a regional stem cell biotechnology company, is to expand its biotechnology business and research and development activities in Indonesia following a strategic partnership with PT Kimia Farma TBK (Kimia Farma).
Cellsafe, through its subsidiary, PT Cellsafe International, Friday signed a memorandum of understanding (MoU) with Kimia Farma, a leading integrated healthcare services companies in Indonesia.
Cellsafe Executive Director Lau Kin Wai said the comprehensive partnership involved co-branding and co-marketing arrangements that would allow the group to harness the vast resources and indepth market knowledge of Kimia Farma.
Kimia Farma operates one of the largest network pharmacies in Indonesia, with more than 400 outlets and owns more than 80 pharmacies in different hospitals.
"Cellsafe has set up one of the largest stem cell cryogenic laboratories in Indonesia. With this partnership, we will be constructing a new state-of-art stem laboratory at a co-located facility with Kimia Farma Diagnostic," he told reporters after the MoU signing. (*)